No Data
ICON Public Limited Company (ICLR) Slid on Drop in Biotechnology Funding
Mizuho Securities Maintains Icon PLC(ICLR.US) With Buy Rating, Announces Target Price $260
ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research
Icon Analyst Ratings
Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?
ICON Names Barry Balfe Chief Operating Officer